HealthDay - THURSDAY, Dec. 10 (HealthDay News) -- Adding chemotherapy to
standard cancer-suppressing tamoxifen can boost reworking in postmenopausal
women with the most common type of breast cancer, known as estrogen
receptor-positive, and it's best given before the tamoxifen regimen
starts, gospel to a new study.

More: - From the site